secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0001818331-23-000027
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx amends Executive Chairman agreement: reduced time, base salary $337,500
------------------------------------------------------------------------------

- Jason Ryan's employment as Executive Chairman extended to Dec 31, 2023.
- For 2023, Ryan will work 50% time with base salary of $337,500.
- Target annual performance bonus for 2023 set at 100% of base salary.
- Amendment effective April 10, 2023; prior vesting End Date unchanged as Dec 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000027/0001818331-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000027/smfr-20230412.htm
  HTML page:      https://secwatch.observer/filing/0001818331-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer